MedTrace Logo

The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

NCT00280085 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2009-08-07

No results posted yet for this study

Summary

Assess pancreatic beta cell function using MR imaging.

Conditions

Interventions

PROCEDURE

MR imaging

PROCEDURE

Glucose clamp

DRUG

Arginine

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00280085 on ClinicalTrials.gov